Cat.#: ACPP-1255
| Despition | MC3 Receptor Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1251 | EAAT2 Blocking Peptide (AC1251) | 250 µg | inquiry |
| ACPP-1154 | Recombinant Human FGF19 Protein (6×His Tag) (AC1154) | 50 µg | inquiry |
| ACPP-1612 | Human Vimentin Protein, GST (AC1612) | 2 µg | inquiry |
| ACPP-1712 | Human NME2 Protein (AC1712) | 5 µg | inquiry |
| ACPP-1194 | Calcium Sensing Receptor Blocking Peptide (AC1194) | 250 µg | inquiry |
| ACPP-1417 | Human STMN3 Protein (AC1417) | 2 µg | inquiry |
| ACPP-1376 | Mouse S100A5 Protein (AC1376) | 5 µg | inquiry |
| ACPP-1018 | Recombinant Human APLP2 Protein (6×His Tag) (AC1018) | 50 µg | inquiry |
| ACPP-1801 | Human TEN1 Protein (AC1801) | 2 µg | inquiry |
| ACPP-1578 | Human QPCT Protein (AC1578) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.